Malaysian Genomics partners IMU University for graduate trainee programme


KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd via its wholly-owned subsidiary MGRC Therapeutics Sdn Bhd is collaborating with IMU University on its graduate trainee programme for healthcare professionals.

In a statement, the genomics and biopharmaceutical specialist said the programme offers MU graduates from the Bachelor of Applied Science (Hons) in Medical Biotechnology and Bachelor of Science (Hons) in Biomedical Science an opportunity to gain hands-on experience in the genomics and biopharmaceutical industry.

It said the participants will receive mentorship from industry experts, exposure to cutting-edge technologies, and involvement in groundbreaking research projects.

The group added that the programme also offers a smooth transition to the workforce with the possibility of full employment based on performance.

"By providing practical training and career opportunities, we are not only contributing to the personal and professional growth of these graduates but also reinforcing our commitment to sustainable and responsible business practices,” said Malaysian Genomics executive chairman Azri Azerai.

Said IMU University group managing director Professor Gerard George: "By partnering with a leading industry player like MGRC, we can ensure that our graduates are equipped with the practical skills and industry knowledge necessary to excel in the rapidly evolving fields of genomics and biopharmaceuticals.”

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MGRC , genomics , IMU , training

Next In Business News

Sentral REIT appoints Tay Hui Ling as CEO
Mega First to acquire 12.5% stake in Stenta Films for RM33.10mil
DXN inks MoU with Apex-Brasil to explore Brazil, eyes US$50mil investments
F&N to focus on innovation, diversification and transformation
Mulpha International invests US$20mil in Hong Kong's Sun Hung Kai bond programme
Ringgit breaches 4.04 level against US dollar after OPR maintained at 2.75%
Capital A’s Teleport to raise US$50mil via perpetual securities
Apex Healthcare to be delisted on Jan 27
Prudential to raise stake in Malaysia life insurer holding firm to 70% for US$377mil
BWYS shareholders approve RM67mil property disposal, RM94.5mil land acquisition

Others Also Read